Human Vaccines & Immunotherapeutics (Jan 2022)

CIMT 2021: report on the 18th Annual Meeting of the Association for Cancer Immunotherapy

  • Arne Billmeier,
  • Krutika Khinvasara,
  • Franziska Lang,
  • Julia Mohr,
  • Daniel Reidenbach,
  • Maik Schork,
  • Ikra Yildiz,
  • Mustafa Diken

DOI
https://doi.org/10.1080/21645515.2021.2024416
Journal volume & issue
Vol. 18, no. 1

Abstract

Read online

After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021.

Keywords